Juvenescence ^Investors

Juvenescence is a biotech company that focuses on extending healthy human lifespan through aging research and the development of therapies to counter age-related diseases. They are also known for their ketone ester drink, Metabolic Switch. The company is dedicated to developing novel therapeutics that modify the way we age, with a strong emphasis on prevention. They have a unique and integrated pipeline, which has facilitated robust investor returns. Currently, Juvenescence is developing ten leading programs with a clearly defined route to market, covering the entire aging market with a variety of advanced therapeutic interventions.